(Q74570763)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12161082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

A meta-analytic approach to an integrated summary of efficacy: a case study of becaplermin gel (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12161082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

Barbara H Perry

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12161082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Allan R Sampson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12161082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Barry H Schwab

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12161082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

M Rezaul Karim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12161082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Janice M Smiell

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12161082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 August 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12161082%20AND%20SRC:MED&resulttype=core&format=json

Contemporary Clinical Trials

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12161082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12161082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12161082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

389-408

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12161082%20AND%20SRC:MED&resulttype=core&format=json

Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900220-9

7 January 2021

Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900220-9

7 January 2021

Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900220-9

7 January 2021

Platelet-derived growth factor BB for the treatment of chronic pressure ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900220-9

7 January 2021

Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900220-9

7 January 2021

Comparison of meta-analysis versus analysis of variance of individual patient data

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900220-9

7 January 2021

10.1016/S0197-2456(02)00220-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12161082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference